Cargando…

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer

BACKGROUND: PCDH8 is a novel tumor suppressor gene, and frequently inactivated by promoter methylation in human cancers. However, there is little information regarding PCDH8 methylation in non-muscle invasive bladder cancer (NMIBC). The aim of this study was to investigate the methylation status of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ying-Li, Wang, Yan-Ling, Ma, Jian-Guo, Li, Wen-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237820/ https://www.ncbi.nlm.nih.gov/pubmed/25927589 http://dx.doi.org/10.1186/s13046-014-0068-7

Ejemplares similares

Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer
por: Lin, Ying-Li, et al.
Publicado: (2017)

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2016)

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016)

Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma
por: Yu, Hong, et al.
Publicado: (2020)

Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2017)

Promoter Methylation of Protocadherin8 is an Independent Prognostic Factor for Biochemical Recurrence of Early-Stage Prostate Cancer
por: Niu, Wen-Bin, et al.
Publicado: (2014)

Adjuvant Treatment for Protocadherin 19 (PCDH19) Syndrome
por: Moncayo, Juan A, et al.
Publicado: (2022)

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy
por: Lin, Ying-Li, et al.
Publicado: (2015)

Biallelic mutation of Protocadherin-21 (PCDH21) causes retinal degeneration in humans
por: Henderson, Robert H., et al.
Publicado: (2010)

Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014)

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance
por: Zhang, Cheng, et al.
Publicado: (2016)

Protocadherin‐8 promotes invasion and metastasis via laminin subunit γ2 in gastric cancer
por: Lin, Ying, et al.
Publicado: (2018)

Understanding Protein Protocadherin-19 (PCDH19) Syndrome: A Literature Review of the Pathophysiology
por: Moncayo, Juan A, et al.
Publicado: (2022)

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
por: Huang, Wenting, et al.
Publicado: (2017)

Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer
por: Cao, Yuan, et al.
Publicado: (2018)

Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2015)

Aberrant Methylation of Protocadherin 17 and its Clinical Significance in Patients with Prostate Cancer after Radical Prostatectomy
por: Lin, Ying-Li, et al.
Publicado: (2014)

The protocadherin 11X/Y (PCDH11X/Y) gene pair as determinant of cerebral asymmetry in modern Homo sapiens
por: Priddle, Thomas H, et al.
Publicado: (2013)

The Clustered Gamma Protocadherin Pcdhγc4 Isoform Regulates Cortical Interneuron Programmed Cell Death in the Mouse Cortex
por: Leon, Walter R Mancia, et al.
Publicado: (2023)

Protocadherin-10 is involved in angiogenesis and methylation correlated with multiple myeloma
por: LI, YING, et al.
Publicado: (2012)

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2017)

Retraction: Overexpression of PCDH8 inhibits proliferation and invasion, and induces apoptosis in papillary thyroid cancer cells
por: Fisher, Laura
Publicado: (2021)

The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome
por: Miyake, Kunio, et al.
Publicado: (2011)

Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα)
por: Pham, Duyen H., et al.
Publicado: (2017)

Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
por: Wang, Li, et al.
Publicado: (2014)

Clustered protocadherins methylation alterations in cancer
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2019)

Retracted Article: Overexpression of PCDH8 inhibits proliferation and invasion, and induces apoptosis in papillary thyroid cancer cells
por: Chang, Liang, et al.
Publicado: (2018)

Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors
por: Lee, Na Keum, et al.
Publicado: (2016)

The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer
por: Zhang, Shitong, et al.
Publicado: (2021)

Chromobox homolog 8 is a predictor of muscle invasive bladder cancer and promotes cell proliferation by repressing the p53 pathway
por: Yuan, Gang‐jun, et al.
Publicado: (2017)

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer
por: Chen, Liuxi, et al.
Publicado: (2019)

Sequencing and comparative analysis of fugu protocadherin clusters reveal diversity of protocadherin genes among teleosts
por: Yu, Wei-Ping, et al.
Publicado: (2007)

Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
por: He, Ya, et al.
Publicado: (2019)

Protocadherin-18 Is a Novel Differentiation Marker and an Inhibitory Signaling Receptor for CD8(+) Effector Memory T Cells
por: Vazquez-Cintron, Edwin J., et al.
Publicado: (2012)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
por: Shibata, Mami, et al.
Publicado: (2020)

Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
por: Liu, Wentao, et al.
Publicado: (2018)

PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer
por: Elsharkawi, Sherif Mohamed, et al.
Publicado: (2023)

Expression of protocadherin gamma in skeletal muscle tissue is associated with age and muscle weakness
por: Hangelbroek, Roland W. J., et al.
Publicado: (2016)

MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10
por: Qi, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qioqdgr79qpaj9gjbcl2rr73e7